February 11, 2020

ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »

February 6, 2020

ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH) Read More »

ProSciento - Top Work Places


View Our Presentation


March 2, 2020

Clinical Research Strategies to Drive Advances in Obesity Drug Development Read More »

January 8, 2020

NASH Patient Access and Screening Strategies or NASH PASS: An epidemiological, multicenter, prospective screening registry for adults with nonalcoholic steatohepatitis Read More »

December 14, 2019

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »

Stay Connected

Would you like to receive updates from ProSciento?

I'm interested in receiving: